Prohibits procurement of opioid antidotes from certain entities.
Introduced First Reading Senate Referred to SHH
Summary
The bill requires the Division of Purchase and Property and any state agency that contracts for goods to buy opioid overdose medications only from manufacturers or distributors that have never settled opioid‑related claims with any state. Companies that have settled, including their affiliates, are barred from bidding or selling, except when a settlement entered before September 1 2024 obligates them to continue supplying the antidotes. The goal is to ensure the state sources life‑saving drugs from firms not tied to the opioid crisis.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when S 3904 changes status, plus AI-powered summaries and stage predictions.
Sign up free